
NeuroMetrix NURO
Quarterly report 2024-Q3
added 05-16-2026
NeuroMetrix Long Term Debt Current 2011-2026 | NURO
Annual Long Term Debt Current NeuroMetrix
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107 K | 148 K | 148 K | 229 K | 600 K | 589 K | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 600 K | 107 K | 303 K |
Long Term Debt Current of other stocks in the Medical instruments industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
The Cooper Companies
COO
|
37.8 M | $ 68.62 | - | $ 13.7 B | ||
|
Glaukos Corporation
GKOS
|
1.31 M | $ 126.34 | - | $ 7.23 B | ||
|
Alcon
ALC
|
80 M | $ 67.9 | - | $ 40.4 B | ||
|
Intuitive Surgical
ISRG
|
39 M | $ 426.61 | - | $ 152 B | ||
|
ICU Medical
ICUI
|
13.8 M | $ 142.0 | - | $ 3.5 B | ||
|
iRhythm Technologies
IRTC
|
16.7 M | $ 113.83 | - | $ 3.64 B | ||
|
Repro Med Systems
KRMD
|
413 K | $ 4.0 | - | $ 185 M | ||
|
LeMaitre Vascular
LMAT
|
2.94 M | $ 96.59 | - | $ 2.19 B | ||
|
Masimo Corporation
MASI
|
21.4 M | $ 179.95 | 0.01 % | $ 9.59 B | ||
|
Microbot Medical
MBOT
|
296 K | $ 1.82 | - | $ 83.3 M | ||
|
Ekso Bionics Holdings
EKSO
|
441 K | - | - | $ 28.6 M | ||
|
Milestone Scientific
MLSS
|
130 K | $ 0.39 | - | $ 32 M | ||
|
Merit Medical Systems
MMSI
|
10.9 M | $ 67.51 | - | $ 3.99 B | ||
|
electroCore
ECOR
|
375 K | $ 9.52 | -1.24 % | $ 80.8 K | ||
|
Envista Holdings Corporation
NVST
|
39 M | $ 24.59 | - | $ 4.13 B | ||
|
Haemonetics Corporation
HAE
|
9.24 M | $ 78.71 | - | $ 3.71 B | ||
|
Isoray
ISR
|
623 K | - | 0.03 % | $ 108 M | ||
|
STERIS plc
STE
|
35.8 M | $ 212.88 | - | $ 20.9 B | ||
|
STAAR Surgical Company
STAA
|
5.87 M | $ 29.87 | -0.3 % | $ 1.48 B | ||
|
InfuSystem Holdings
INFU
|
349 K | $ 9.01 | - | $ 186 M | ||
|
Utah Medical Products
UTMD
|
60 K | $ 68.07 | 1.52 % | $ 221 M | ||
|
Teleflex Incorporated
TFX
|
100 M | $ 135.75 | - | $ 6.06 B | ||
|
West Pharmaceutical Services
WST
|
22.7 M | $ 334.66 | - | $ 24.2 B | ||
|
Pulse Biosciences
PLSE
|
1.57 M | $ 25.77 | - | $ 1.74 B | ||
|
DENTSPLY SIRONA
XRAY
|
47 M | $ 10.47 | - | $ 2.09 B | ||
|
Retractable Technologies
RVP
|
332 K | $ 0.69 | - | $ 20.7 M | ||
|
Predictive Oncology
POAI
|
654 K | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
2.24 M | $ 27.55 | - | $ 1.32 B | ||
|
Stereotaxis
STXS
|
642 K | $ 1.85 | - | $ 168 M | ||
|
Baxter International
BAX
|
81 M | $ 20.03 | - | $ 10.3 B | ||
|
ResMed
RMD
|
21.9 M | $ 196.94 | -0.02 % | $ 28.8 B | ||
|
AtriCure
ATRC
|
1.73 M | $ 27.3 | - | $ 1.3 B | ||
|
Harvard Bioscience
HBIO
|
1.52 M | $ 6.04 | - | $ 268 M | ||
|
AngioDynamics
ANGO
|
1.84 M | $ 12.34 | 3.44 % | $ 504 M | ||
|
Becton, Dickinson and Company
BDX
|
135 M | $ 152.04 | - | $ 43.7 B | ||
|
Nephros
NEPH
|
386 K | $ 3.25 | - | $ 34.5 M | ||
|
OraSure Technologies
OSUR
|
2.16 M | $ 4.24 | 2.17 % | $ 312 M | ||
|
Repligen Corporation
RGEN
|
21.6 M | $ 130.13 | - | $ 7.32 M |